-
1
-
-
7144227956
-
Principles of treatment of malignant gliomas in adults: An overview
-
Azizi S.A., Miyamoto C. Principles of treatment of malignant gliomas in adults An overview . J Neurovirol. 4:1998;204-216.
-
(1998)
J Neurovirol
, vol.4
, pp. 204-216
-
-
Azizi, S.A.1
Miyamoto, C.2
-
2
-
-
0030854355
-
Current perspectives in gliomas
-
Brock C.S., Bower M. Current perspectives in gliomas. Med Oncol. 14:1997;103-120.
-
(1997)
Med Oncol
, vol.14
, pp. 103-120
-
-
Brock, C.S.1
Bower, M.2
-
4
-
-
0027172819
-
Temozolomide a new oralcytotoxic chemotherapeutic agent with promising activity against primary brain tumors
-
O'Reilly S.M., Newlands E.S., Glaser M.G., et al. Temozolomide a new oralcytotoxic chemotherapeutic agent with promising activity against primary brain tumors. Eur J Cancer. 29A:1993;940-942.
-
(1993)
Eur J Cancer
, vol.29
, pp. 940-942
-
-
O'Reilly, S.M.1
Newlands, E.S.2
Glaser, M.G.3
-
5
-
-
0030449301
-
The Charing Cross experience with temozolomide in patients with gliomas
-
Newlands E.S., O'Reilly S.M., Glaser M.G., et al. The Charing Cross experience with temozolomide in patients with gliomas. Eur J Cancer. 32A:1996;2236-2241.
-
(1996)
Eur J Cancer
, vol.32
, pp. 2236-2241
-
-
Newlands, E.S.1
O'Reilly, S.M.2
Glaser, M.G.3
-
6
-
-
0030765194
-
Multicenter CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
-
Bower M., Newlands E.S., Bleehen N.M., et al. Multicenter CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol. 40:1997;484-488.
-
(1997)
Cancer Chemother Pharmacol
, vol.40
, pp. 484-488
-
-
Bower, M.1
Newlands, E.S.2
Bleehen, N.M.3
-
7
-
-
17644443014
-
Phase I study of temozolomide in paediatric patients with advanced cancer
-
Estlin E.J., Lashford L., Ablett S., et al. Phase I study of temozolomide in paediatric patients with advanced cancer. Br J Cancer. 78:1998;652-661.
-
(1998)
Br J Cancer
, vol.78
, pp. 652-661
-
-
Estlin, E.J.1
Lashford, L.2
Ablett, S.3
-
8
-
-
0023605735
-
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine
-
Stevens M.F.G., Hickman J.A., Langdon S.P., et al. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res. 47:1987;5846-5852.
-
(1987)
Cancer Res
, vol.47
, pp. 5846-5852
-
-
Stevens, M.F.G.1
Hickman, J.A.2
Langdon, S.P.3
-
9
-
-
0031426782
-
Pharmacokinetics of 3-methyl (triazen-1 y)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer
-
Reid J.M., Stevens D.C., Rubin J., et al. Pharmacokinetics of 3-methyl (triazen-1 y)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer. Clin Cancer Res. 3:1997;2393-2398.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 2393-2398
-
-
Reid, J.M.1
Stevens, D.C.2
Rubin, J.3
-
10
-
-
0030479125
-
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl) nitrosourea
-
Liu L., Markovitch S., Gerson S.L. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl) nitrosourea. Cancer Res. 56:1996;5375-5379.
-
(1996)
Cancer Res
, vol.56
, pp. 5375-5379
-
-
Liu, L.1
Markovitch, S.2
Gerson, S.L.3
-
11
-
-
0026750738
-
Self-destruction and tolerance in resistance of mammalian cells to alkylation damage
-
Karran P., Bignami M. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acid Res. 20:1992;2933-2940.
-
(1992)
Nucleic Acid Res
, vol.20
, pp. 2933-2940
-
-
Karran, P.1
Bignami, M.2
-
13
-
-
0031052506
-
In vitro evaluation of temozolomide combined with x-irradiation
-
Wedge S.R., Porteous J.K., Glaser M.G., et al. In vitro evaluation of temozolomide combined with x-irradiation. Anti-Cancer Drugs. 8:1997;92-97.
-
(1997)
Anti-Cancer Drugs
, vol.8
, pp. 92-97
-
-
Wedge, S.R.1
Porteous, J.K.2
Glaser, M.G.3
-
14
-
-
0018128359
-
Properties of human malignant glioma cells in vitro
-
Pontén J., Westermark B. Properties of human malignant glioma cells in vitro. Med Biol. 56:1978;184-193.
-
(1978)
Med Biol
, vol.56
, pp. 184-193
-
-
Pontén, J.1
Westermark, B.2
-
15
-
-
0022485676
-
D-1 dopaminergic and β-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM
-
Balmforth A.J., Ball S.G., Freshney R.I., et al. D-1 dopaminergic and β-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM. J Neurochem. 47:1986;515-719.
-
(1986)
J Neurochem
, vol.47
, pp. 515-719
-
-
Balmforth, A.J.1
Ball, S.G.2
Freshney, R.I.3
-
16
-
-
0028174027
-
6-alkylguanine-DNA alkyltransferase in human periferal blood mononuclear cells by temozolomide
-
6-alkylguanine-DNA alkyltransferase in human periferal blood mononuclear cells by temozolomide. Br J Cancer. 69:1994;452-456.
-
(1994)
Br J Cancer
, vol.69
, pp. 452-456
-
-
Lee, S.M.1
Thatcher, N.2
Crowther, D.3
-
17
-
-
0023617794
-
In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas
-
Catapano C.V., Broggini M., Erba E., et al. In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas. Cancer Res. 47:1987;4884-4889.
-
(1987)
Cancer Res
, vol.47
, pp. 4884-4889
-
-
Catapano, C.V.1
Broggini, M.2
Erba, E.3
-
18
-
-
0028026692
-
Preclinical antitumor activity of temozolomide in mice: Efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea
-
Plowman J., Waud W.R., Koutsoukos A.D., et al. Preclinical antitumor activity of temozolomide in mice Efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea . Cancer Res. 54:1994;3793-3799.
-
(1994)
Cancer Res
, vol.54
, pp. 3793-3799
-
-
Plowman, J.1
Waud, W.R.2
Koutsoukos, A.D.3
-
19
-
-
0022930310
-
6-methylguanine-DNA methyltransferase activity induced by various treatments in mammalian cells
-
6-methylguanine-DNA methyltransferase activity induced by various treatments in mammalian cells. Cancer Res. 46:1986;5701-5705.
-
(1986)
Cancer Res
, vol.46
, pp. 5701-5705
-
-
Lefebvre, P.1
Laval, F.2
-
21
-
-
0023818419
-
6-methylguanine-DNA methyltransferase in C3H/10T1/2 cells by x-rays is inhibited by nitrogen
-
6-methylguanine-DNA methyltransferase in C3H/10T1/2 cells by x-rays is inhibited by nitrogen. Carcinogenesis. 9:1988;679-681.
-
(1988)
Carcinogenesis
, vol.9
, pp. 679-681
-
-
Von Hofe, E.1
Kennedy, A.R.2
-
22
-
-
0026701589
-
6 alkylguanine-DNA alkyltransferase activity are equally sensitive to x-rays
-
6 alkylguanine-DNA alkyltransferase activity are equally sensitive to x-rays. Mutation Res. 283:1992;125-129.
-
(1992)
Mutation Res
, vol.283
, pp. 125-129
-
-
Pardini, C.1
Piras, A.2
Voliani, M.3
-
23
-
-
4243207045
-
In vitro synergistic activity of L-buthionine-S,R-sulfoximine (BSO) with BCNU and temozolomide on human glioblastoma multiforme
-
763 (Abstr)
-
Fruehauf JP, Brem H, Parker R; et al. In vitro synergistic activity of L-buthionine-S,R-sulfoximine (BSO) with BCNU and temozolomide on human glioblastoma multiforme. Proceed Am Soc Clin Oncol 1998;17:198a, 763 (Abstr).
-
(1998)
Proceed Am Soc Clin Oncol
, vol.17
-
-
Fruehauf, J.P.1
Brem, H.2
Parker, R.3
-
24
-
-
0025302401
-
Role of glutathione in the radiation response of mammalian cells in vitro and in vivo
-
Bump E.A., Brown J.M. Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. Pharmac Ther. 47:1990;117-136.
-
(1990)
Pharmac Ther
, vol.47
, pp. 117-136
-
-
Bump, E.A.1
Brown, J.M.2
|